Anke Kretz-Rommel

Directeur Technique/Scientifique/R&D chez Bird Rock Bio, Inc.

Health Technology

Commercial Services

Consumer Services

Postes actifs de Anke Kretz-Rommel

Sociétés	Poste	Début	Fin
Bird Rock Bio, Inc. Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA.	Directeur Technique/Scientifique/R&D	27/08/2009	-

Sociétés	Poste	Début	Fin
Alexion Antibody Technologies Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases.	Corporate Officer/Principal	-	-

Swiss Federal Institute of Technology

Doctorate Degree

Internationale

Etats-Unis	3
Suisse	2

Opérationnelle

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Doctorate Degree	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Bird Rock Bio, Inc. Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA.	Health Technology
Alexion Antibody Technologies Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases.	Commercial Services